Two prominent breakfast-focused restaurant groups, a Denny's franchisee in Florida and Taste of Belgium in Ohio, have filed for Chapter 11 bankruptcy, highlighting broader pressures on the casual dining sector as consumer spending tightens.
Sanctuary Wealth has appointed Marissa Fox-Foley, former CMO of Choreo, as its new Chief Marketing Officer. She is tasked with scaling the hybrid RIA's marketing capabilities and driving digital transformation across its network of partner firms.
Divergent analyst ratings on Incyte Corp highlight the debate over the biotech's valuation and its ability to transition beyond its flagship drug Jakafi, with price targets ranging from $107 to $118.
Antero Resources has completed a $750 million senior notes offering to finance its pending purchase of HG Energy II assets, a move analysts view as a strategic consolidation play in the Appalachian Basin amid mixed price target revisions.
New Phase II trial data for roflumilast cream indicates a favorable safety profile and significant improvement in disease severity for infants with mild to moderate eczema, addressing a critical gap in pediatric dermatology.
Shares of Pilgrim's Pride Corporation (NASDAQ:PPC) have surged 17% in the last quarter, outpacing the broader market. This analysis delves into the key financial metric driving investor optimism—Return on Equity (ROE)—and examines whether the stock's rally is built on sustainable fundamentals or ripe for a correction.
As the Eurozone economy shows signs of steady, consumption-led growth, discerning investors are scanning the markets for hidden value. We analyze three European companies trading at significant discounts to their estimated fair value, offering potential opportunities in a complex landscape.
Corporate insiders at FTAI Infrastructure Inc. have invested over $2.7 million in the company's stock over the past year, a notable vote of confidence as the firm navigates the competitive infrastructure sector.
A 13-year-old boy swam four kilometers through treacherous waters off Western Australia's coast to alert rescuers after his mother and two siblings were swept out to sea, in an act described by emergency crews as "superhuman."
The FDA has issued a complete response letter for Aquestive's sublingual epinephrine film Anaphylm, requesting new human factors studies. The company aims to resubmit its application by Q3 2026 while advancing regulatory efforts in Europe and Canada.
In a near-unanimous vote, TC Transcontinental shareholders have cleared the path for the sale of its packaging division to U.S.-based ProAmpac, a major consolidation in the flexible packaging industry set to conclude in early 2026.
Twin Disc, Incorporated announces a $0.04 per share dividend payable in March, but a history of cuts and a high earnings payout ratio raise flags for income-focused investors.
A landmark shift in bankruptcy policy has dramatically improved success rates for student loan borrowers seeking discharge. Despite its efficacy, experts warn that a critical lack of awareness and lingering skepticism among attorneys is preventing a debt-laden generation from accessing this vital lifeline.
Analysts at Leerink Partners have raised their price target for Bristol-Myers Squibb (BMY), highlighting a series of pivotal clinical trial results expected in 2025. The firm sees significant upside potential as the market currently undervalues the company's robust pipeline, despite near-term earnings adjustments.
Goldman Sachs maintains a Neutral stance on Pfizer (PFE) with a $26 price target, as the pharmaceutical giant navigates significant margin pressures from looming patent expiries and a constrained business development budget.
A viral social media trend looking back at 2016 has sparked a sobering financial reality check. New analysis reveals the dramatic loss of purchasing power for what was once considered a lofty income milestone, with essential costs soaring far beyond headline inflation rates.
Shares of nutritional supplements maker USANA have tumbled over 25% in six months, trading near $21.66. While the valuation appears reasonable, underlying weaknesses in revenue growth and profitability are prompting investors to consider alternatives.
Coherent Corp. is set to report its fiscal fourth-quarter results after Wednesday's closing bell. With a strong track record of surpassing estimates, investors are watching for signs of sustained growth in the materials and photonics sector amid mixed peer performance.
As work-life balance eclipses salary as a top priority, a seismic shift is underway. The defining workplace conflict of 2024 is no longer about *where* people work, but *when*. Experts argue that granting 'time autonomy'—control over schedules and focus blocks—is now the critical lever for talent retention and performance.
While large-cap stocks dominate headlines, a select group of small and mid-cap companies are posting robust fundamentals and growth that defy the cautious market mood. We spotlight three such firms from Asia's tech and industrial sectors that analysts believe are trading below their intrinsic value.
